1. Abetimus: Abetimus sodium, LJP 394;BioDrugs,2003
2. LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study;Alarcon-Segovia;Arthritis Rheum.,2003
3. Mycophenolate mofetil and its mechanisms of action;Allison;Immunopharmacology,2000
4. New treatments for SLE: cell-depleting and anti-cytokine therapies;Anolik;Best Pract. Res. Clin. Rheumatol.,2005
5. Appel, G.B., Dooley, M.A., Ginzler, E.M., Isenberg, D., Jayne, D., Solomons, N., Wofsy, D. 2007. Mycophenolate mofetil compared with intravenous cyclophosphamide as induction therapy for lupus nephritis: Aspreva Luypus Management Study (ALMS) results [ASN abst 2007].